April 2014
Volume 55, Issue 13
ARVO Annual Meeting Abstract  |   April 2014
Extracellular HMGB1 promotes choroidal angiogenesis
Author Affiliations & Notes
  • Younghee Kim
    Ophthalmology & Visual Sciences, University of Kentucky, Lexington, KY
  • Nagaraj Kerur
    Ophthalmology & Visual Sciences, University of Kentucky, Lexington, KY
  • Shengjian Li
    Ophthalmology & Visual Sciences, University of Kentucky, Lexington, KY
  • Ana Bastos-Carvalho
    Ophthalmology & Visual Sciences, University of Kentucky, Lexington, KY
  • Bradley D Gelfand
    Ophthalmology & Visual Sciences, University of Kentucky, Lexington, KY
  • William W Hauswirth
    University of Florida, Gainesville, FL
  • Jayakrishna Ambati
    Ophthalmology & Visual Sciences, University of Kentucky, Lexington, KY
  • Footnotes
    Commercial Relationships Younghee Kim, None; Nagaraj Kerur, None; Shengjian Li, None; Ana Bastos-Carvalho, None; Bradley Gelfand, None; William Hauswirth, None; Jayakrishna Ambati, University of Kentucky (P)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 4459. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Younghee Kim, Nagaraj Kerur, Shengjian Li, Ana Bastos-Carvalho, Bradley D Gelfand, William W Hauswirth, Jayakrishna Ambati; Extracellular HMGB1 promotes choroidal angiogenesis. Invest. Ophthalmol. Vis. Sci. 2014;55(13):4459.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: High mobility group box 1 (HMGB1) protein acts as a cellular alarm against pathologic inflammation and its extracellular release by acetylation has been reported to be required for its angiogenic cytokine function. HMGB1 has been recently suggested as a novel therapeutic target for angiogenesis; however the association between its acetylation and angiogenic function in vivo is not clear. Here we aim to examine HMGB1 effect on choroidal angiogenesis (CNV) and extracellular HMGB1 expression related to its acetylation.

Methods: To investigate the effect of HMGB1 on angiogenesis, we used a mouse model of laser coagulation-induced CNV and measured CNV volume by FITC-conjugated GS-IB4 staining after treatment of a neutralizing antibody or recombinant protein of HMGB1 in WT mice. To confirm whether HMGB1 protein expression is related to CNV induction, we examined not only total HMGB1 protein but also extracellular HMGB1 protein and its acetylation in retina and retinal pigment epithelium/choroid (RPE/C) from CNV eyes comparing to WT by Western blotting. In addition, we measured CNV volume by RPE-specific knockdown of HMGB1 by subretinal injection of AAV1-VMD2-Cre to HMGB1f/f mice comparing to control AAV1-VMD2-GFP group.

Results: We confirmed that antibody neutralization of HMGB1 reduced CNV, whereas administration of recombinant HMGB1 protein induced CNV, implying that both endogenous and exogenous HMGB1 promote CNV. In Western blotting, total HMGB1 protein abundance did not change in both retina and RPE/C by laser injury, however extracellular HMGB1 release and its acetylation occurred in retina and RPE/C by laser-induced CNV.

Conclusions: Taken together, these data suggest that extracellular HMGB1 by its acetylation is related to CNV development, and control of HMGB1 expression and localization can be a novel therapeutic target for in vivo angiogenesis.

Keywords: 453 choroid: neovascularization • 494 degenerations/dystrophies • 688 retina  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.